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The aetiology of central post-stroke pain (CPSP) is poorly understood and such pains are often refractory
to treatment. We report the case of a 56-year-old man, who, following a temporo-parietal infarct, suf-
fered from debilitating and refractory hemi-body cold dysaesthesia and severe tactile allodynia. This
was associated with thermal and tactile hypoaesthesia and hypoalgesia on his affected side. Implantation
of a deep brain stimulating electrode in his periventricular gray (PVG) region produced an improvement
in his pain that was associated with a striking normalisation of his deﬁcits in somatosensory perception.
This improvement in pain and thermal sensibility was reversed as stimulation became less effective,
because of increased electrode impedance. Therefore, we postulate that the analgesic beneﬁt may have
occurred as a consequence of the normalisation of somatosensory function and we discuss these ﬁndings
in relation to the theories of central pain generation and the potential to engage useful plasticity in cen-
tral circuits.
 2009 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under CC BY license.1. Introduction
Some of the landmark clinical reports of chronic pain following
cerebrovascular events appeared at the turn of the last century
[15,20] however central post-stroke pain (CPSP) remains a poorly
understood condition that is often refractory to treatment [6]. It
is now appreciated that CPSP is a relatively common sequela of
cerebrovascular accidents (CVA), developing in around 8% of pa-
tients [4]. The disease burden of CPSP is increasing as the preva-
lence of stroke rises in our ageing population and it has been
estimated that around 28,000 people suffer from this condition
in the UK [34]. CPSP is characteristically severe, continuous and of-
ten has a hemi-body distribution. Patients report altered thermal
sensation (burning or freezing) and tactile or cold allodynia [25].
Sensory examination often reveals an apparently paradoxical deﬁ-
ciency of warm, cold and touch sensibility in the regions of thermal
and tactile allodynia [7,8].
CPSP may occur secondary to lesions of a range of brain struc-
tures along the neuraxis although it is most commonly associated
with lesions of the sensory thalamus (which can be very discrete
[24]). The unifying pathology seems to be interruption of the trans-tudy of Pain. Published by Elsevie
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Pickering).mission of information in the spino-thalamo-cortical tracts which
convey thermal and pain sensibilities from the periphery (re-
viewed in [6]). This, in part, may account for the association be-
tween CPSP and thermosensory abnormalities. Several potential
neural mechanisms have been proposed to account for the puz-
zling cluster of signs and symptoms of CPSP [8,11,12,29] but as
yet none of these theories have been directly testable in man nor
have they led to therapeutic advances as the pathology has ap-
peared secondary to an irreversible loss of neural function.
Because CPSP patients are poorly responsive to both conven-
tional analgesic therapies and to treatments targeted against neu-
ropathic pains, some groups have examined the role of functional
neurosurgery and central neuromodulation. In particular recent
studies of deep brain stimulation (DBS) and motor cortex stimula-
tion have reported some beneﬁcial effects in refractory CPSP pa-
tients [23,34]. Here we report the case of a 56-year-old man,
who, following a right-sided temporo-parietal infarct, presented
with typical symptoms of CPSP. Quantitative sensory testing prior
to implantation of DBS electrode showed thermal and tactile hyp-
oaesthesia and hypoalgesia on his affected side. After DBS of the
periventricular gray (PVG) region he showed a marked improve-
ment in his pain that was associated with a normalisation of the
deﬁcits in somatosensory perception. This improvement in pain
and thermal sensibility was reversed as stimulation became less
effective, because of increased electrode impedance. Therefore
we suggest that the analgesic beneﬁt may have occurred as ar B.V.Open access under CC BY license.
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we discuss these ﬁndings in relation to the theories of central pain
generation and the potential to engage useful plasticity.
2. Case report
2.1. History and examination
ML, a 56-year-old gentleman, initially presented at the age of
51, with a one day history of headache followed by the sudden on-
set of dense left-sided weakness. His computerised tomography
scan on admission showed ‘‘an area of poorly deﬁned low density re-
lated to the right internal capsule, which most likely represents recent
infarction”. He was a smoker and his past medical history included
longstanding back pain with sciatica secondary to disc prolapse
(which had forced medical retirement from work). While an inpa-
tient he was diagnosed with, and treated for, hypertension and
hypercholesterolemia.
His initial left hemiparesis resolved over 6 weeks but was grad-
ually replaced (from week 3 onwards) by left hemi-body pain
(rated as 10/10 every day). He described having ‘‘frostbite” on
the whole of the left side of his body and such severe tactile allo-
dynia that he found clothing difﬁcult to tolerate. A diagnosis of
central pain syndrome was made and, following referral to a
chronic pain clinic, he was given trials of nortriptyline (60 mg noc-
te), gabapentin (600 mg three times daily), nabilone, acupuncture
and physiotherapy. His pain was refractory to these treatments
and consequently he was referred to a tertiary pain clinic to assess
his suitability for neuromodulation.
At this point, 2 years after his CVA, he described an ‘ice cold’,
dull pain down the left hand side of his body which was worst in
his lower leg and foot. His symptoms were exacerbated by cold
and wet weather. Tactile allodynia was still a prominent feature
and he complained of consequent difﬁculties with normal human
contact. He obtained little beneﬁt from further trials of combina-
tions of strong opiates, pregabalin and tricylic antidepressants.
TENS also failed to provide symptomatic relief. Therefore, a trial
of spinal cord stimulation (SCS) was undertaken with the lead
placed at the T11/12 level with the aim of alleviating the pain in
his leg (his worst pain). However, despite being technically suc-
cessful (evoking paraesthesia in the leg) SCS failed to improve his
pain and was abandoned. Against this background, and after psy-
chological assessment for suitability, ML was scheduled for DBS.
Prior to DBS implantation ML completed baseline pain ques-
tionnaires: Brief Pain Inventory (BPI) [9] and Neuropathy pain scale
(NPS) [17]. We also performed a formal neurological examination
and quantitative sensory testing (QST). He rated his average pain
as 9/10 and his mean pain interference score on BPI was 7.7/10.
He had an overall NPS score of 82/100 (see Table 1 for component
scores).Table 1
Neuropathy pain scale. Scores for each individual aspect of pain (out of 10) assessed
before the insertion of deep brain stimulator and measured again 6 weeks later.










Surface 10 7ML had considerable difﬁculty disrobing because of his hemi-
body allodynia and he forcefully declined a formal peripheral neu-
rological examination of his left upper and lower limbs. Indeed he
ﬂinched and attempted to withdraw whenever contact was
impending or his personal space was encroached on his affected
side. Tone, power, reﬂexes and coordination were all normal on
the unaffected side. Cranial nerve examination was unremarkable
other than left facial tactile allodynia. ML agreed to have QST on
the anterior shin, volar forearm and maxillary areas bilaterally.
Brushing with a cotton bud evoked severe allodynia (10/10 NRS
on face and upper limb) on the left side and mild allodynia on
the right (2/10 NRS). Punctate mechanical sensation was assessed
using von-Frey hairs, showing left-sided hypoaesthesia and hypo-
algesia (Fig. 1A). Assessment of thermal sensation (TSA IITM thermo-
sensory analyser, Medoc, Israel) demonstrated marked warm and
cool hypoaesthesia and hot and cold hypoalgesia on his left side
(Fig. 1B).
2.2. Surgical procedure
Our methods for magnetic resonance imaging guided place-
ment of DBS electrodes have been described by us in detail previ-
ously [35] and are only presented here in outline (shown
schematically in Fig. 2B).
2.2.1. Procedure 1
Under general anaesthesia a modiﬁed MRI compatible Leksell
frame was applied and detailed MRI scans were performed which
showed the extent of the infarct damage to cortical territories
extending from the superior temporal gyrus through the supra-
marginal gyrus to the superior parietal lobule and including the in-
sula. Below the cortex there was damage to the posterior external
and internal capsules and to the ventrolateral thalamus. A trajec-
tory was planned to target the PVG (based on previous reports of
beneﬁt in CPSP [34]) with a trans-ventricular approach (Fig. 2A
and C). This route was chosen to optimise the axial placement of
the stimulating electrode in the PVG/PAG thus maximising the
likelihood of ﬁnding an appropriate stimulus location within this
midline territory.
2.2.2. Procedure 2
The following day the patient was re-anaesthetised and a right
frontal burrhole was made along the planned trajectory. Stereo-
taxic placement of a probe allowed the guide-tube to be railroaded
into position 12 mm from the ﬁnal target. The probe was replaced
by a radio-opaque stylette to target. The correct positioning in the
right periventricular and periaqueductal gray was conﬁrmed on re-
peat MRI scan (Fig. 2D) whereupon the stylette was removed and
replaced with a DBS lead (Medtronic 3387). This was tunnelled
subcutaneously and connected to a pectoral Kinetra generator
(Medtronic).
2.3. Post-operative course
After optimisation of the stimulation parameters (pulse ampli-
tude 2 V, duration 240 ls at 5 Hz) ML’s pain was considerably re-
duced along with a marked improvement in his allodynia. It was
noted, during optimisation, that there was a degree of somatotopy
evident on stimulation with the most proximal (apical) electrodes
affecting sensation from the lower limbs and the caudal electrodes
affecting the face/upper limbs (as previously noted [5]). It was also
apparent that the beneﬁcial effects of stimulation were reversed
(within minutes) if stimulation ceased with pain rapidly returning
to its previous severity.
Some 6 weeks post DBS implantation ML was followed up in
clinic. He had a qualitative symptomatic improvement (pain score
Fig. 1. Baseline pain assessment. (A) Extract from original BPI assessment tool showing hemi-body distribution of pain and score of 10/10 (NRS) for the worst pain in last 24 h.
Overlaid are the results of tactile QST showing profound dynamic allodynia on cotton bud stroke on the left side and an associated insensitivity to static tactile stimuli with
elevated thresholds for detection and pain (assessed with von-Frey hairs). (B) Assessment of thermal detection and pain thresholds showed signiﬁcant elevations of both cold
and warm detection thresholds on the left side (face and leg) and also an increase in the heat and cold (face) pain thresholds indicating the presence of left-sided thermal
hypoaesthesia and hypoalgesia (Students t-test).
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of personal contact. There had been no change in his analgesic
medication during this period (oxycodone and gabapentin).
We again administered the pain questionnaires and repeated
QST. His NPS had reduced from 82 to 49 with a complete resolution
of the deep pain and improvements in the other aspects of 30–50%(Table 1). He estimated the degree of pain relief provided by DBS as
70% and showed improvements in his BPI interference scores. QST
showed that his allodynia had improved considerably in the arm
and face (NRS 4 and 5/10 respectively, Fig. 3) on the affected side
and the mild right-sided allodynia had completely resolved. His
tactile hypoalgesia and hypoaesthesia had also improved on the af-
Fig. 2. DBS system implantation. (A) Axial planning MRI scan (inverted T2 weighted) showing atrophic area of infarct territory in right fronto-parietal cortex (including
insula) extending to internal capsule (3 years after the original infarct). (B) Schematic of implant showing the guide-tube containing the DBS lead inserted to target. (C)
Coronal MRI planning view (inverted T2 weighted) showing the target area in the periventricular gray (PVG) and the intended trans-ventricular electrode track (dotted lines).
(D) Peri-operative MRI (T2 weighted) showing position of the stylette (dotted lines) in the target region.
Fig. 3. DBS attenuates dynamic tactile allodynia. Brush strokes with a cotton bud
(2–3 cm/s over a 6 cm distance) evoked severe tactile allodynia down his left side
(worst in arm and face 10/10 NRS) with milder allodynia evoked on the right. Six
weeks after PVG DBS there was a clear improvement in allodynia with around a 50%
reduction on the affected side and a complete resolution on the right.
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from 21 to 0.6 g and the pricking threshold from 40.5 to 6.2 g.
Equally striking was the change in thermal thresholds (Fig. 4A)
with almost complete resolution of the previous left-sided hypoal-
gesia and hypoaesthesia without any signiﬁcant corresponding
change in the thresholds on the right (Fig. 4B).
ML was reviewed in clinic, some 4 months after implantation,
because of a gradual deterioration in his pain control. He stated
that his pain had returned towards pre-operative levels and this
was borne out by his BPI assessment which showed his average
pain as 10/10 NRS with an average interference score of 9.4/10
NRS. Interrogation of his DBS system revealed that the impedance
across the contacts of the stimulating electrode had almost dou-
bled and the stimulation parameters needed to be adjusted. Repeat
QST at this point (prior to DBS adjustment) showed that the left-
sided thermal (but not punctate mechanical) hypoalgesia and hyp-
oaesthesia had returned along with the evoked dynamic allodynia
(7–8/10). After adjustment of his DBS parameters (increased pulse
amplitude), a signiﬁcant improvement in both his pain and allo-
dynia was achieved (he declined further QST after this adjust-
ment). Over the following year the beneﬁt from DBS was not
maintained and there was an increase in his pain scores. However,
he was unwilling to turn the stimulator off as he found this wors-
ened his pain, suggesting the stimulation was still producing some
analgesic effect.
Fig. 4. Resolution of thermal sensory abnormalities with DBS. (A) QST of affected
left side (medial shin, volar forearm and maxilla) before and after DBS Showed the
presence of cold and warm hypoaesthesia and cold hypoalgesia. After PVG DBS
there was a signiﬁcant improvement in the cold detection and cold pain thresholds
with a trend also seen towards normalisation of the warm detection threshold. (B)
Comparison of the left and right upper limbs before and after DBS. The signiﬁcant
side-to-side differences in thermal detection and cold pain thresholds were
resolved by PVG DBS (repeated measures ANOVA with Bonferoni post tests
*p < 0.05, **p < 0.01, ***p < 0.001).
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We have presented a patient with a severe, refractory central
pain syndrome following a temporo-parietal infarct manifesting
as hemi-body pain with cold dysaesthesia and marked tactile allo-
dynia. This was associated with thermal hypoaesthesia and hypo-
algesia along with decreased punctate tactile sensation. DBS of
the periventricular gray produced a striking analgesic effect with
reduced allodynia that was associated with resolution of the
hemi-body hypoaesthesia and hypolagesia. Unfortunately, this
improvement lasted less than 9 months and as his pain returned
so his sensory loss recurred. This is therefore the ﬁrst report of
therapeutic restoration of sensory function associated with an
improvement in CPSP symptoms.
Head and Holmes [20] suggested central pain was caused by loss
of speciﬁc pain and temperature pathways as a result of damage to
the lateral thalamus disinhibiting themedial thalamic nucleus. This
hypothesis has been re-formulated to postulate that the loss of in-
put in the neo-spinothalamic tract removes the sensori-discrimina-
tive aspects of pain input leaving the phylogenetically older medial
pain pathways intact and without their usual regulation [8].
A further reﬁnement of the disinhibition theory suggests that it
is the loss of normal cool sensory input from the periphery thatremoves a tonic inhibitory inﬂuence on thalamic wide-dynamic
range neurones giving rise to the sensation of burning pain and
allodynia [11,12]. Craig has also implicated the insula as having a
role in the generation of CPSP [13]. This is consistent with the
observation that parietal cortex lesions involving the insula can
produce CPSP [40] with similar symptomatology as that exhibited
by ML. However, QST in a series of CPSP patients has not shown the
predicted close association between cold hypoaesthesia and cold
allodynia [18] suggesting that this hypothesis alone does not ac-
count for the pain in all subjects.
All of these preceding hypotheses emphasise the role of ana-
tomical damage to sensory pathways as being the fundamental
mechanism responsible for the generation of CPSP. There have also
been suggestions of functional deﬁcits; for example it has been
proposed that there are alterations within the reticular nucleus
of the thalamus leading to an atypical oscillating pattern of neural
activity and thence to altered sensory transmission through the
thalamus [29]. Consistent with this idea is the observation of
abnormal excitability of thalamic units in patients with deafferen-
tation pains [39]. A similar observation has been made in patients
with CPSP who have abnormal oscillatory thalamic ﬁeld potentials
at 0.2–0.4 Hz that were attenuated by PVG DBS [32]. These ﬁndings
suggest CPSP may be a consequence of a functional thalamic dys-
rhythmia as proposed by Llinas et al. [26,27]. It is worthy of note
that thalamic dysrhythmias have also been implicated in the
pathology of other neurological disorders such as Parkinson’s dis-
ease, and it has been suggested that the beneﬁcial effects of DBS
in Parkinson’s disease may be due to an improvement in such dys-
rhythmias [27].
Stimulation of deep brain structures has been used as a therapy
in a variety of forms for over 40 years [2,22,38] and has targeted a
range of structures including thalamic nuclei [31] and the periaqu-
eductal and periventricular gray (PAG and PVG) [21]. Although
CPSP was originally considered to be poorly responsive to DBS,
some recent reports have indicated that DBS may be of beneﬁt
for some patients [23,34]. Owen et al. [34] found better results in
the treatment of CPSP when stimulating the periventricular gray
region as compared to thalamus and we found a similar effect in
our case. However, no previous DBS study has ever noted an
improvement in sensory function associated with the analgesic
beneﬁt in CPSP (or indeed any other neuropathic pain condition).
Intriguingly, there has been a report of an improvement in motor
symptoms (upper limb paresis) by PVG DBS for CPSP in a patient
with a posterior cerebral artery territory infarct [36].
The initial hypothesis underpinning the introduction of DBS
was based on dramatic animal studies that showed electrical stim-
ulation of the periaqueductal gray (PAG) evoked profound analge-
sia [30,37]. These animal studies went onto suggest that this
analgesia was, at least in part, a result of activation of an endoge-
nous opioid system [3] thought to involve a descending relay in the
medulla to alter nociception at the level of the spinal cord. There is
evidence supporting a role of endogenous opioids in the mediation
of the analgesic effect of DBS in patients [1,21,42] but there are also
non-opioidergic mechanisms (reviewed by Duncan et al. [16]).
It would seem unlikely that release of endogenous opiates alone
could account for the improvements in sensory function noted to
accompany the analgesic beneﬁt seen in ML. Rather, the release of
endogenous opioids would have been expected to increase pain
thresholds (infusion of opioids increases heat pain threshold with-
out effect on cold pain threshold [19]). It is noteworthy that there
are ascending connections from the PAG to the thalamus in prima-
tes [28]. Such projections have previously been proposed to be
responsible for the damping action of PVG DBS on the aberrant tha-
lamic activity seen in CPSP [32]. If such thalamic dysrhythmia is in-
deed responsible for the generation of both the positive (allodynia
and spontaneous pain) and negative features (hypoalgesia and hyp-
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account for the ability of DBS to reversibly improve apparently
‘‘hard wired” neurological deﬁcits in ML. Alterations in thalamic
function have also been suggested to underlie some of the beneﬁ-
cial effects seen with motor cortex stimulation in CPSP [33,41].
Although these ﬁndings are encouraging, unfortunately the
analgesic beneﬁts of DBS were relatively short-lived in the case
of ML, due to increased electrode impedance (perhaps secondary
to local gliosis) which limited the effectiveness of stimulation. It
is also possible that ML developed stimulation tolerance as has
been seen with DBS for other chronic pains (reviewed in [10]).
The limited evidence base supporting the use of DBS in CPSP has
lead the European Federation of Neurological Societies (EFNS) to
advise that indications for DBS in CPSP are ‘equivocal’ and that fur-
ther comparative trials are necessary [14] a recommendation that
we fully endorse.
In conclusion we report a case of refractory CPSP due to a large
temporo-parietal infarct that was improved by DBS of the PVG.
This improvement was associated with a normalisation of hemi-
body sensory inattention. Although we cannot prove causation,
we speculate that the beneﬁcial action of DBS of the PVG in this
case is via restoration of normal sensory transmission of innocuous
exteroceptive stimuli to higher centres perhaps by an action on the
thalamus. This holds out the promise that even in the case of
extensive CNS damage the pain generating mechanisms may be
amenable to neuromodulatory approaches such as DBS.
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